This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Novartis Ag, University of Pennsylvania. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 3,978 
3 out of 2,663 
Years Active: 2019-2025
Title: Innovations of Eugene Choi: Pioneering Cancer Treatment
Introduction
Eugene Choi is an accomplished inventor based in Cambridge, MA, with a focus on groundbreaking innovations in cancer treatment. With three patents to his name, his contributions to the field of biomedical research are significant. His work, particularly in developing chimeric antigen receptors, is poised to enhance therapeutic options for patients suffering from diseases related to BCMA expression.
Latest Patents
Eugene Choi's latest patents include advancements in the treatment of cancer using humanized anti-BCMA chimeric antigen receptors. His inventions provide novel compositions and methods for addressing diseases associated with the expression of BCMA. These patents encompass vectors encoding chimeric antigen receptors specific to BCMA, as well as recombinant T cells that include the BCMA CAR. Furthermore, he has developed methodologies for administering genetically modified T cells that express a CAR featuring a BCMA binding domain. This innovative approach has the potential to transform how certain cancers are treated.
Career Highlights
Choi has made significant strides during his career, having worked with prestigious organizations such as Novartis AG and the University of Pennsylvania. His experience at these institutions has allowed him to collaborate with leading professionals in the field, enhancing his knowledge and expertise in medical research and development.
Collaborations
Throughout his career, Eugene Choi has collaborated with notable coworkers, including Jennifer Brogdon and Hilmar Erhard Ebersbach. Working alongside such talented individuals has contributed to his innovative ideas and his ability to bring transformative treatments to the forefront of cancer therapy.
Conclusion
Eugene Choi's passion for innovation in cancer treatment is reflected in his patents and collaborations. His work in developing anti-BCMA chimeric antigen receptors exemplifies the importance of research and innovation in improving patient outcomes. As he continues to advance his work, the medical community eagerly anticipates the future impact of his inventions on cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile